Reshape Lifesciences Inc Share Price Nasdaq
Equities
US7611234052
Advanced Medical Equipment & Technology
Sales 2024 * | 99.94L 83Cr | Sales 2025 * | 1.2Cr 100Cr | Capitalization | 43.44L 36Cr |
---|---|---|---|---|---|
Net income 2024 * | -60L -50Cr | Net income 2025 * | -50L -42Cr | EV / Sales 2024 * | 0.43 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.36 x |
P/E ratio 2024 * |
-0.41
x | P/E ratio 2025 * |
-0.51
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.83% |
Latest transcript on Reshape Lifesciences Inc
Managers | Title | Age | Since |
---|---|---|---|
Paul Hickey
CEO | Chief Executive Officer | 59 | 01/20/01 |
Director of Finance/CFO | 63 | 15/21/15 | |
Dov Gal
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Blackford
BRD | Director/Board Member | 66 | 01/16/01 |
Dan Gladney
CHM | Chairman | 70 | 01/15/01 |
Director/Board Member | 70 | 15/21/15 |
1st Jan change | Capi. | |
---|---|---|
+11.18% | 23TCr | |
+15.22% | 20TCr | |
+19.19% | 14TCr | |
+30.89% | 11TCr | |
+1.56% | 6.42TCr | |
+18.48% | 5.41TCr | |
+5.12% | 5.14TCr | |
+10.53% | 4.53TCr | |
+5.98% | 3.73TCr |